Dr Terrafranca of NeuroRecovery Technologies discusses commercialisation of treatments

Posted on: December 20, 2016 Categorized in: Research

Dr. Nick Terrafranca explains in detail the many facets involved in the commercialization process of a given therapy. Dr Terrafranca is the CEO of NeuroRecovery Technologies, the start-up working with Prof Reggie Edgerton to commercialise Prof Edgerton’s spinal neurostimulation breakthrough.

Electroconductive 3-D scaffold to help regrow spinal nerves

Researchers have developed an electro-conductive 3-D scaffold which can bridge the gap created by the injury.

Celebrating a fundraising milestone at the Sydney Everest Carnival Long Lunch

What a spectacular afternoon celebrating style, racing, and philanthropy! With over 450 guests in attendance, this year’s Sydney Everest Carnival Long Lunch was the biggest ever and marked our third year as the ATC Foundation’s charity partner. Importantly, we are…

Navigating the Complexities of Clinical Trial Recruitment: Barriers and Solutions

One of the biggest challenges as a researcher is the recruitment of participants for our clinical trials.

Get a Grip Broadens Reach to Spinal Injured South Australians

Our Get a Grip clinical trial recently expanded its footprint to South Australia, with the trial welcoming its first participants at a new site based at NeuroMoves in Angle Park. Get a Grip is an exercise trial designed for individuals with complete or…

The Countdown Begins to the Sydney Everest Carnival Long Lunch – Friday 6 September

SpinalCure’s life-changing spinal cord injury (SCI) research projects will be in the spotlight at the highly anticipated Sydney Everest Carnival Long Lunch on Friday 6 September at Royal Randwick Racecourse. Led by the Australian Turf Club and the ATC Foundation…

Introduction

Dr Terrafranca of NeuroRecovery Technologies discusses commercialisation of treatments